Concepedia

Author

Erica N. Borducchi

Beth Israel Deaconess Medical Center

Also Known As

Borducchi, Érica Nogueira, E Borducchi, Erica Borducchi, Erica N Borducchi, Erica N. Borducchi, Erica N. Borducchi, van Hoof, Johan, É. Borducchi, Érica Borducchi, Érica Nogueira Borducchi

99

Publications

7.9K

Citations

37

H-Index

50

Concepts

All Affiliations

Beth Israel Deaconess Medical CenterRagon Institute of MGH, MIT and HarvardBioqualWalter Reed Army Institute of ResearchJanssen (Netherlands)
EN

About

Erica N. Borducchi is an author at Beth Israel Deaconess Medical Center specializing in medicine, immunology, and vaccination.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

26

3.8K

2

Immunology

21

23

3K

3

Allergy

3

3

81

4

Cell Biology

1

1

25

5

Neurology

1

1

209

Erica N. Borducchi

×

62

Publications

7.6K

Citations

37

H-Index

YearCitations

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

Dan H. Barouch, James B. Whitney, Brian Moldt,

Nature

2013

628

Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys

James B. Whitney, Alison L. Hill, Srisowmya Sanisetty,

Nature

2014

621

Vaccine protection against Zika virus from Brazil

Rafael A. Larocca, Peter Abbink, Jean Pierre Schatzmann Peron,

Nature

2016

514

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

Peter Abbink, Rafael A. Larocca, Rafael A. De La Barrera,

Science

2016

500

Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women

Ai‐ris Y. Collier, Katherine McMahan, Jingyou Yu,

JAMA

2021

411

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

Galit Alter, Jingyou Yu, Jinyan Liu,

Nature

2021

342

Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys

Dan H. Barouch, Kathryn E. Stephenson, Erica N. Borducchi,

Cell

2013

337

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Dan H. Barouch, Frank Tomaka, Frank Wegmann,

The Lancet

2018

334

Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19

Kathryn E. Stephenson, Mathieu Le Gars, Jerald Sadoff,

JAMA

2021

313

Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

Erica N. Borducchi, Jinyan Liu, Joseph P. Nkolola,

Nature

2018

309

Page 1